BMY
Bristol-Myers Squibb Company$58.09+0.30 (+0.53%)Prev Close$57.78·MCap$120.73B·P/E16.84·Vol2.99M·Yield0.04%
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
13
$5.43M
◆
Net Activity
Net Seller
$5.43M
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Bristol-Myers Squibb Company (BMY) has been exclusively selling, with 0 insider purchases totaling $0.00 and 13 insider sales totaling $5.43M. The most recent insider transaction was by Elkins David V (officer: EVP, Chief Financial Officer), who sold $1.85M worth of shares on Apr 2, 2026. Bristol-Myers Squibb Company operates in the Healthcare sector, within the Drug Manufacturers - General industry, with a market cap of $120.73B.
BMY Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Elkins David V | officer: EVP, Chief Financial Officer | Sell | 30,000 | $61.67 | $1.85M | 163,729 |
| Feb 1, 2026 | Hickey Benjamin | President, RayzeBio Org. | Sell | 3,810 | $55.05 | $209.7K | 0 |
| Feb 1, 2026 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 833 | $55.05 | $45.9K | 0 |
| Nov 4, 2025 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Sell | 1,238 | $46.07 | $57.0K | 0 |
| Nov 4, 2025 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Sell | 3,213 | $46.07 | $148.0K | 0 |
| Nov 1, 2025 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 2,665 | $46.07 | $122.8K | 0 |
| Oct 2, 2025 | Gallman Cari | EVP, General Counsel | Sell | 2,332 | $45.73 | $106.6K | 0 |
| Sep 2, 2025 | Elkins David V | EVP, Chief Financial Officer | Sell | 56,000 | $47.33 | $2.65M | 0 |
| Sep 1, 2025 | Short Bartie Wendy | EVP, Corporate Affairs | Sell | 632 | $47.18 | $29.8K | 0 |
| Aug 2, 2025 | Short Bartie Wendy | EVP, Corporate Affairs | Sell | 378 | $44.23 | $16.7K | 0 |
| Aug 1, 2025 | Gallman Cari | EVP, General Counsel | Sell | 543 | $44.23 | $24.0K | 0 |
| Jun 3, 2025 | Short Bartie Wendy | EVP, Corporate Affairs | Sell | 3,334 | $48.09 | $160.3K | 0 |
| May 9, 2025 | Hickey Benjamin | President, RayzeBio Org. | Sell | 97 | $38.16 | $3.7K | 0 |
| Apr 25, 2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | 4,250 | $47.58 | $202.2K | 0 |
| Apr 1, 2025 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Sell | 1,692 | $59.55 | $100.8K | 0 |
| Mar 12, 2025 | Hoch Lynelle | President, Cell Therapy Org. | Sell | 2,248 | $63.11 | $141.9K | 0 |
| Mar 12, 2025 | Holzer Phil M | SVP and Controller | Sell | 1,578 | $63.11 | $99.6K | 0 |
| Mar 12, 2025 | Lenkowsky Adam | EVP, Chief Commercial Officer | Sell | 6,065 | $63.11 | $382.8K | 0 |
| Mar 12, 2025 | Poole Ahn Amanda | EVP, Chief People Officer | Sell | 2,273 | $63.11 | $143.4K | 0 |
| Mar 12, 2025 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Sell | 7,173 | $63.11 | $452.7K | 0 |
| Mar 10, 2025 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Sell | 21,797 | $63.11 | $1.38M | 0 |
| Mar 10, 2025 | Elkins David V | EVP, Chief Financial Officer | Sell | 20,935 | $63.11 | $1.32M | 0 |
| Mar 10, 2025 | Gallman Cari | EVP, Corporate Affairs | Sell | 1,940 | $63.11 | $122.4K | 0 |
| Mar 10, 2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Sell | 16,056 | $63.11 | $1.01M | 0 |
| Mar 10, 2025 | LEUNG SANDRA | EVP, General Counsel | Sell | 17,710 | $63.11 | $1.12M | 0 |
| Mar 10, 2025 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 6,711 | $63.11 | $423.5K | 0 |
| Mar 10, 2025 | Plenge Robert M | EVP, Chief Research Officer | Sell | 3,610 | $63.11 | $227.8K | 0 |
| Mar 4, 2025 | Hickey Benjamin | President, RayzeBio Org. | Sell | 1,630 | $59.62 | $97.2K | 0 |
| Feb 20, 2025 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Buy | 2,000 | $55.05 | $110.1K | 0 |
| Feb 19, 2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | 1,823 | $54.85 | $100.0K | 0 |
| Feb 4, 2025 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 833 | $58.95 | $49.1K | 0 |
| Feb 1, 2025 | Hickey Benjamin | President, RayzeBio Org. | Sell | 3,725 | $58.95 | $219.6K | 0 |
| Nov 4, 2024 | Holzer Phil M | SVP and Controller | Sell | 700 | $55.62 | $38.9K | 0 |
| Nov 1, 2024 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Sell | 1,488 | $54.32 | $80.8K | 0 |
| Nov 1, 2024 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | 1,830 | $54.67 | $100.1K | 0 |
| Oct 2, 2024 | Gallman Cari | EVP, Corporate Affairs | Sell | 1,648 | $53.76 | $88.6K | 0 |
| Aug 1, 2024 | Gallman Cari | EVP, Corporate Affairs | Sell | 384 | $48.17 | $18.5K | 0 |
| Apr 1, 2024 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Sell | 1,196 | $52.99 | $63.4K | 0 |
| Mar 10, 2024 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Sell | 16,932 | $53.79 | $910.8K | 0 |
| Mar 10, 2024 | Caforio Giovanni | Executive Chair of the Board | Sell | 67,823 | $53.79 | $3.65M | 0 |
| Mar 10, 2024 | Elkins David V | EVP, Chief Financial Officer | Sell | 18,522 | $53.79 | $996.3K | 0 |
| Mar 10, 2024 | Gallman Cari | EVP, Corporate Affairs | Sell | 696 | $53.79 | $37.4K | 0 |
| Mar 10, 2024 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Sell | 13,649 | $53.79 | $734.2K | 0 |
| Mar 10, 2024 | Hoch Lynelle | President, Cell Therapy Org. | Sell | 1,308 | $53.79 | $70.4K | 0 |
| Mar 10, 2024 | Holzer Phil M | SVP and Controller | Sell | 1,389 | $53.79 | $74.7K | 0 |
| Mar 10, 2024 | Lenkowsky Adam | EVP, Chief Commercial Officer | Sell | 4,323 | $53.79 | $232.5K | 0 |
| Mar 10, 2024 | LEUNG SANDRA | EVP, General Counsel | Sell | 16,660 | $53.79 | $896.1K | 0 |
| Mar 10, 2024 | Plenge Robert M | EVP, Chief Research Officer | Sell | 1,965 | $53.79 | $105.7K | 0 |
| Mar 10, 2024 | Poole Ahn Amanda | EVP, Chief Human Resources | Sell | 1,375 | $53.79 | $74.0K | 0 |
| Feb 1, 2024 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 754 | $48.67 | $36.7K | 0 |
Showing 1–50 of 148
1 / 3
BMY Insider Buying Activity
The following table shows recent insider purchases of Bristol-Myers Squibb Company (BMY) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 25, 2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | 4,250 | $47.58 | $202.2K | 0 |
| Feb 20, 2025 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Buy | 2,000 | $55.05 | $110.1K | 0 |
| Feb 19, 2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | 1,823 | $54.85 | $100.0K | 0 |
| Nov 1, 2024 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | 1,830 | $54.67 | $100.1K | 0 |
BMY Insider Selling Activity
The following table shows recent insider sales of Bristol-Myers Squibb Company (BMY) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Elkins David V | officer: EVP, Chief Financial Officer | Sell | 30,000 | $61.67 | $1.85M | 163,729 |
| Feb 1, 2026 | Hickey Benjamin | President, RayzeBio Org. | Sell | 3,810 | $55.05 | $209.7K | 0 |
| Feb 1, 2026 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 833 | $55.05 | $45.9K | 0 |
| Nov 4, 2025 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Sell | 1,238 | $46.07 | $57.0K | 0 |
| Nov 4, 2025 | Shanahan Karin | EVP, Chief Supply Chain & Ops | Sell | 3,213 | $46.07 | $148.0K | 0 |
| Nov 1, 2025 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 2,665 | $46.07 | $122.8K | 0 |
| Oct 2, 2025 | Gallman Cari | EVP, General Counsel | Sell | 2,332 | $45.73 | $106.6K | 0 |
| Sep 2, 2025 | Elkins David V | EVP, Chief Financial Officer | Sell | 56,000 | $47.33 | $2.65M | 0 |
| Sep 1, 2025 | Short Bartie Wendy | EVP, Corporate Affairs | Sell | 632 | $47.18 | $29.8K | 0 |
| Aug 2, 2025 | Short Bartie Wendy | EVP, Corporate Affairs | Sell | 378 | $44.23 | $16.7K | 0 |
| Aug 1, 2025 | Gallman Cari | EVP, General Counsel | Sell | 543 | $44.23 | $24.0K | 0 |
| Jun 3, 2025 | Short Bartie Wendy | EVP, Corporate Affairs | Sell | 3,334 | $48.09 | $160.3K | 0 |
| May 9, 2025 | Hickey Benjamin | President, RayzeBio Org. | Sell | 97 | $38.16 | $3.7K | 0 |
| Apr 1, 2025 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Sell | 1,692 | $59.55 | $100.8K | 0 |
| Mar 12, 2025 | Hoch Lynelle | President, Cell Therapy Org. | Sell | 2,248 | $63.11 | $141.9K | 0 |
| Mar 12, 2025 | Holzer Phil M | SVP and Controller | Sell | 1,578 | $63.11 | $99.6K | 0 |
| Mar 12, 2025 | Lenkowsky Adam | EVP, Chief Commercial Officer | Sell | 6,065 | $63.11 | $382.8K | 0 |
| Mar 12, 2025 | Poole Ahn Amanda | EVP, Chief People Officer | Sell | 2,273 | $63.11 | $143.4K | 0 |
| Mar 12, 2025 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Sell | 7,173 | $63.11 | $452.7K | 0 |
| Mar 10, 2025 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Sell | 21,797 | $63.11 | $1.38M | 0 |
| Mar 10, 2025 | Elkins David V | EVP, Chief Financial Officer | Sell | 20,935 | $63.11 | $1.32M | 0 |
| Mar 10, 2025 | Gallman Cari | EVP, Corporate Affairs | Sell | 1,940 | $63.11 | $122.4K | 0 |
| Mar 10, 2025 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Sell | 16,056 | $63.11 | $1.01M | 0 |
| Mar 10, 2025 | LEUNG SANDRA | EVP, General Counsel | Sell | 17,710 | $63.11 | $1.12M | 0 |
| Mar 10, 2025 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 6,711 | $63.11 | $423.5K | 0 |
| Mar 10, 2025 | Plenge Robert M | EVP, Chief Research Officer | Sell | 3,610 | $63.11 | $227.8K | 0 |
| Mar 4, 2025 | Hickey Benjamin | President, RayzeBio Org. | Sell | 1,630 | $59.62 | $97.2K | 0 |
| Feb 4, 2025 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 833 | $58.95 | $49.1K | 0 |
| Feb 1, 2025 | Hickey Benjamin | President, RayzeBio Org. | Sell | 3,725 | $58.95 | $219.6K | 0 |
| Nov 4, 2024 | Holzer Phil M | SVP and Controller | Sell | 700 | $55.62 | $38.9K | 0 |
| Nov 1, 2024 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Sell | 1,488 | $54.32 | $80.8K | 0 |
| Oct 2, 2024 | Gallman Cari | EVP, Corporate Affairs | Sell | 1,648 | $53.76 | $88.6K | 0 |
| Aug 1, 2024 | Gallman Cari | EVP, Corporate Affairs | Sell | 384 | $48.17 | $18.5K | 0 |
| Apr 1, 2024 | Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Sell | 1,196 | $52.99 | $63.4K | 0 |
| Mar 10, 2024 | BOERNER CHRISTOPHER S. | Chief Executive Officer | Sell | 16,932 | $53.79 | $910.8K | 0 |
| Mar 10, 2024 | Caforio Giovanni | Executive Chair of the Board | Sell | 67,823 | $53.79 | $3.65M | 0 |
| Mar 10, 2024 | Elkins David V | EVP, Chief Financial Officer | Sell | 18,522 | $53.79 | $996.3K | 0 |
| Mar 10, 2024 | Gallman Cari | EVP, Corporate Affairs | Sell | 696 | $53.79 | $37.4K | 0 |
| Mar 10, 2024 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Sell | 13,649 | $53.79 | $734.2K | 0 |
| Mar 10, 2024 | Hoch Lynelle | President, Cell Therapy Org. | Sell | 1,308 | $53.79 | $70.4K | 0 |
| Mar 10, 2024 | Holzer Phil M | SVP and Controller | Sell | 1,389 | $53.79 | $74.7K | 0 |
| Mar 10, 2024 | Lenkowsky Adam | EVP, Chief Commercial Officer | Sell | 4,323 | $53.79 | $232.5K | 0 |
| Mar 10, 2024 | LEUNG SANDRA | EVP, General Counsel | Sell | 16,660 | $53.79 | $896.1K | 0 |
| Mar 10, 2024 | Plenge Robert M | EVP, Chief Research Officer | Sell | 1,965 | $53.79 | $105.7K | 0 |
| Mar 10, 2024 | Poole Ahn Amanda | EVP, Chief Human Resources | Sell | 1,375 | $53.79 | $74.0K | 0 |
| Feb 1, 2024 | Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Sell | 754 | $48.67 | $36.7K | 0 |
BMY Insiders
BOERNER CHRISTOPHER S.
EVP, Chief Commercial Officer
Bought $359.7KSold $10.14M
14 tradesLast: Nov 4, 2025
Similar Stocks to BMY
LLY
Eli Lilly and Company
$865.58-0.35%
$869.14B
JNJ
Johnson & Johnson
$226.84+0.65%
$555.94B
ABBV
AbbVie Inc.
$197.07-0.13%
$360.31B
MRK
Merck & Co., Inc.
$110.37+0.13%
$289.58B
AMGN
Amgen Inc.
$338.27-0.58%
$188.76B
GILD
Gilead Sciences, Inc.
$128.99+0.99%
$168.65B
PFE
Pfizer Inc.
$26.52-1.03%
$156.54B
BIIB
Biogen Inc.
$183.22+1.33%
$26.91B